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ABSTRACT
Protein synthesis is a classic molecular mechanism of cell biology that is taught in introductory 
biology classrooms. It involves the translation of messenger ribonucleic acid (mRNA) information 
into proteins, the building blocks of life. The initial step of protein synthesis consists of the eu-
karyotic translation initiation factor 4E (eIF4E) binding to the 5’cap of mRNAs. A variety of stress-
es repress translation to conserve energy because protein synthesis requires over half of a cell’s 
energy supply. An important stress for multicellular animals is low oxygen availability (hypoxia). 
This causes a repression of cap-directed translation by inhibiting eIF4E. This raises a fundamental 
question in cell biology as to how proteins are synthesized in periods of oxygen scarcity and eIF4E 
inhibition. Here, we describe an oxygen-regulated translation initiation complex that mediates 
selective cap-dependent protein synthesis. Hypoxia stimulates the formation of a complex that in-
cludes the oxygen-regulated hypoxia-inducible factor 2α (HIF-2α), the RNA binding protein RBM4 
and the cap-binding eIF4E2, an eIF4E homologue. We also identified an RNA hypoxia response ele-
ment (rHRE) that recruits this complex to a wide array of mRNAs, including the epidermal growth 
factor receptor (EGFR), which plays a role in growth signaling and proliferation. Once assembled 
at the rHRE, HIF-2α/RBM4/eIF4E2 captures the 5’cap and targets mRNAs for active translation 
thereby evading hypoxia-induced repression of protein synthesis. These findings demonstrate that 
cells have evolved a program whereby oxygen availability switches the basic translation initiation 
machinery.
INTRODUCTION
The appearance of oxygen in Earth’s atmo-sphere 3 billion years ago was a key event 
in evolution.  It gave rise to eukaryotic cells 
that utilized aerobic metabolism to produce 
16-18 times more energy than anaerobic me-
tabolism. This higher energy supply allowed 
complex multicellular organisms such as 
mammals to emerge. With increased size came 
the requirement of sophisticated oxygen-deliv-
ery systems including blood and blood vessels. 
The cells of the human body have intricate 
oxygen-sensing mechanisms which closely 
monitor fluctuations. One of the major cellular 
responses to low oxygen availability (hypox-
ia) is through the stabilization of Hypoxia 
Inducible Factors (HIFs). HIFs are composed 
of oxygen-regulated alpha subunits HIF-1α or 
HIF-2α and a beta subunit (HIF-1β), which is
always expressed. The HIFs are transcription
factors, transcribing DNA into mRNA that
codes for proteins which will allow the cell to 
adapt to hypoxia1. Transcription is the first step 
in gene expression whereby DNA is transcribed 
into mRNA using the cellular language of nu-
cleic acids. This is typically followed by trans-
lation of these mRNAs into another language, 
amino acids, which are the building blocks of 
proteins. Proteins make up most of the func-
tional macromolecules in the cell. A major 
question in cell biology has been how these 
hypoxia-response mRNAs are translated into 
proteins because as hypoxia induces a robust 
transcriptional response, it also represses trans-
lation (protein synthesis) to conserve energy.
 Most (>95%) of protein synthesis is ini-
tiated at one end of the mRNA (the 5’ end), by 
a complex of proteins that includes one protein 
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drastically reduces translation rates. Such is 
the case during exposure to hypoxia, which 
reduces eIF4E activity, and therefore drastically 
reduces translation rates. Since translation of 
certain proteins is required for the adaptation 
to hypoxia to take place, other mechanisms of 
translation must occur when eIF4E is repressed.
 This is an important question because 
hypoxia has implications in many physiolog-
ical processes, as well as in many of today’s 
most deadly diseases. Proper embryonic devel-
opment depends on the hypoxic response to 
build a thorough blood vessel network to fully 
oxygenate the foetus. Intense muscle exercise 
requires a switch to anaerobic metabolism and 
the synthesis of key proteins involved in the 
glycolytic pathway. Populations that live at 
high altitudes or temporary visitors to these 
locations must deal with lower atmospheric ox-
ygen levels to avoid mountain sickness, which 
could be fatal. Many of the most deadly diseas-
es in North America are driven by the hypoxic 
response such as stroke, heart disease and 
cancer. Stroke and heart disease are the result 
of a blockage in a blood vessel, restricting the 
delivery of oxygen to the affected organs often 
causing irreversible tissue damage. Cancer can 
result in the development of a tumor, a cellular 
mass that quickly outgrows its blood supply 
resulting in massive regions of hypoxia. Tumor 
hypoxia has been linked to poor prognosis due 
to the resistance to chemo and radiation ther-
apy and has been a primary target of cancer 
therapy for decades. Our research goals were 
to better understand the mechanisms behind 
how human cells translate mRNA into protein 
during the harsh conditions of hypoxia, which 
would allow us to better appreciate how the 
abovementioned processes are regulated.
HOW WE DID IT
Cell lines and reagents. All human cell lines 
(U87MG glioblastoma and human renal prox-
imal tubular epithelial cells) were obtained 
from the American Type Culture Collection and 
propagated grown as suggested. Cells were 
incubated at 37 oC in a 5% CO2 environment. 
Hypoxia was induced by incubation at 1% O2, 
5% CO2 and N2-balanced atmosphere for 24 h. 
actinomycinD, a transcription inhibitor (10 µg/
mL) was added 30 min prior to hypoxic expo-
sure.
Protein synthesis by 35S-Methionine incor-
poration. Prior to cell lysis, cells were labeled 
with radioactive [35S]Methionine for 15 min 
to visualize newly-synthesized proteins (pro-
teins are the only macromoleculaes to contain 
sulphur). Cells were lysed in 1 mL RIPA lysis 
buffer.  Samples were separated by a method 
known as SDS-polyacrylamide gel electropho-
resis (SDS-PAGE), which separates proteins by 
size, and then exposed to X-ray film overnight 
and visualized by autoradiography.
RNA Immunoprecipitation. Messenger RNAs 
were crosslinked to proteins with formalde-
hyde and cells were lysed in 1 mL RIPA. HIF-
2α and RBM4 were precipitated with 2 µg/mL 
of primary antibody overnight. Target proteins 
were captured with Dynabeads, which were 
washed five times with RIPA. Crosslinking 
was reversed by incubating overnight at 65 
oC. RNAs associated with HIF-2α or RBM4 
were extracted with TRIzol and amplified with 
reverse-transription-polymerase chain reaction 
(RT-PCR) analysis.
Cap-binding assays. Cells were lysed and 
incubated with 50 µL 7-methyl GTP-Sepharose 
4B beads (5’ cap linked to beads) for 1 h. Beads 
were washed 4 times with lysis buffer and 
resuspended in 1 mM GTP for 1 h (GTP is a 
competitor for the beads and will dislodge the 
bound proteins). Samples were separated on an 
SDS-PAGE.
Polysome analysis. Polysome analysis was 
performed by trapping ribosomes on mRNAs 
with the inhibitor of translocation cyclohexim-
ide, lysing cells, and then loading them onto a 
linear 10-50% sucrose density gradient (which 
will separate cellular components by densi-
ty). The dense polysomes will be isolated and 
probed by Western blot for various components 
of the translation apparatus such as eIF4E and 
eIF4E2.
PAR-CLIP. Cells were irradiated with 365 nm 
UV light and lysed. Immunoprecipitations 
of HIF-2α and RBM4 were performed as de-
scribed above. Radioactive 32P-ATP was added 
to label the ends of the associated mRNAs so 
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that they could be detected by SDS-PAGE and 
autoradiography. The radioactive RNA-protein 
complex migrating at the expected molecular 
weight of the target protein was excised from 
the gel. The proteins were removed by Protein-
ase K digestion and the RNA was recovered by 
acidic phenol/chloroform extraction followed 
by a chloroform extraction and ethanol pre-
cipitation. The RNA pellet was dissolved in 
10 µL of water and amplified by RT-PCR after 
binding of the appropriate adapter sequenc-
es for Next Generation Sequencing. Samples 
were sequenced by Illumina next generation 
sequencing at the Next Generation Sequencing 
Facility (Hospital for Sick Children, Toronto, 
Ontario). Sequence reads were analyzed with 
CLC Genomics Workbench 4.7.1. Associated 
mRNA sequences were identified using Basic 
Local Alignment Search Tool mapped against 
the human genomic transcript database down-
loaded from Genbank.
WHAT WE FOUND
HIF-2α has an alter ego as a translation factor.  
The major finding that led us down the path of 
translational control was that many key hypox-
ia-induced proteins that were HIF-2α-depen-
dent accumulated in the presence of transcrip-
tion inhibitors. This was consistent with a role 
of HIF-2α outside of transcription. We further 
investigated the role of HIF-2α as a transla-
tion factor by monitoring its association with 
hypoxic polysomes (mRNAs that are being 
actively translated). Indeed, HIF-2α associat-
ed with hypoxic polysomes and directly with 
the epidermal growth factor receptor (EGFR) 
mRNA, which is a key hypoxia-induced pro-
tein that allows cells to survive hypoxic stress. 
Furthermore, when we reduced the levels of 
HIF-2α in the cell by RNA interference, we 
observed no interaction of HIF-2α with the 
EGFR mRNA and a drastic reduction in global 
hypoxic protein synthesis rates by radioactive 
sulphur incorporation even in the presence of 
transcription inhibitors. This decrease in over-
all protein synthesis suggests that HIF-2α plays 
a role in global hypoxic translation. Interesting-
ly, reducing the levels of its HIF-1α or HIF-1β 
had no effect on hypoxic protein synthesis 
rates highlighting the role of HIF-2α outside of 
transcription and independent activities from 
its closely related homolog HIF-1α. We next set 
out to investigate how HIF-2α could associate 
with mRNA without a classical RNA recogni-
tion motif in its protein sequence.
An interaction with RBM4 allows HIF-2α to asso-
ciate with hundreds of mRNAs.
We performed immunoprecipitations (IPs) of 
HIF-2α and HIF-1α followed by mass spec-
trometry to identify proteins that preferentially 
associated with HIF-2α under hypoxia since we 
knew that HIF-1α was not involved in protein 
synthesis. A protein of interest was identified 
as RNA binding motif protein 4 (RBM4). RBM4 
had been previously shown to be involved 
in mRNA splicing and translation activation 
during cellular stress. Consistent with a role in 
translation, reducing levels of cellular RBM4 
prevented HIF-2α from associating with the 
EGFR mRNA and repressed global hypoxic 
protein synthesis rates. To gain a better under-
standing of which mRNAs, and how many, 
were being recruited for active translation by 
HIF-2α and RBM4, we utilized a technique 
named photoactivatable ribonucleoside cross-
linking and IP (PAR-CLIP). This technique 
allowed us to specifically isolate the HIF-2α 
molecules that interacted with RBM4 and to 
identify the mRNAs that were associated with 
this complex. More importantly, PAR-CLIP also 
reveals which sequences within the mRNAs 
recruit this complex. We were able to identify 
hundreds of mRNAs that bound the HIF-2α/
RBM4 complex at specific sequences located in 
the 3’ untranslated region (3’ UTR). Many of 
these mRNAs code for proteins involved in the 
hypoxic response including a few key cancer 
hallmarks expressed in the cores of hypoxic 
tumors such as EGFR, platelet-derived growth 
factor receptor alpha (PDGFRA), and insulin 
growth factor 1 receptor (IGF1R). Interesting-
ly, this 3’ UTR sequence could be attached to 
any mRNA (even non-human mRNA) and 
transform it into a hypoxia-induced molecule. 
We termed this sequence the RNA Hypoxia 
Response Element (rHRE). Our next goal was 
to identify whether this was a cap-dependent 
Canadian Young Scientist Journal • La Revue Canadienne de Jeunes Scientifiques #3.2014 
56
Figure 1  (Model of normoxic and hypoxic cap-dependent translation). A novel translation initiation complex mediates 
selective cap-dependent protein synthesis during hypoxia and eIF4E inactivation.
1. The mRNAs containing RNA hypoxia response elements (rHRE) are targeted for translation under hypoxia. PAR-
CLIP (Photoactivatable ribonucleoside-enhanced crosslinking-immunoprecipitation) analysis indentified rHREs in the 
3’UTR of hundreds of mRNAs.
2. The RNA binding motif protein 4 (RBM4) constitutively associates with rHRE-containing transcripts.
3. Hypoxia inducible factor 2α (HIF-2α) associates with RBM4 in response to low oxygen.
4. The HIF-2α/RBM4 complex recruits eIF4E2 to rHRE-containing mRNAs.
5. The eIF4E2/HIF-2α/RBM4 complex binds the 5’ cap, targets the mRNAs to polysomes, and initiates translation.
6. The rHRE enables selective expression of the hypoxic cell proteome; other transcripts are not translated.
or cap-independent mechanism. A clue lay in 
our observation that, while mRNAs required 
rHREs in their 3’ UTR to be translated in hy-
poxia, any 5’ UTR sequence could be attached 
to these mRNAs, but they did require a 5’ UTR.
An alternative cap-binding protein is responsible 
for a robust cap-dependent translation program that 
escapes mTOR repression during hypoxia.
A universal feature of mRNA 5’ UTRs is a 
5’ cap. Therefore we first wanted to test the 
possibility that cap-dependent translation 
could occur in the absence of eIF4E. A thorough 
literature review revealed that only the eIF4E 
family of proteins could bind the 5’ cap. There 
are three members of this family: eIF4E, eIF4E2, 
and eIF4E32. eIF4E is inactive in hypoxia while 
eIF4E3 expression is restricted to muscle, lung 
and spleen. eIF4E2 is a good candidate for 
stress-mediated translation because it is not 
recognized by the 4E-BPs. We monitored the 
association of eIF4E2 with HIF-2α and RBM4 
by performing IPs. eIF4E2 associated with HIF-
2α and RBM4 only during hypoxia, and was 
required for the accumulation of key hypox-
ia-response proteins such as EGFR, PDGFRA, 
and IGF1R. Moreover, mRNA targets identified 
by PAR-CLIP associated with hypoxic poly-
somes in an eIF4E2-dependent manner. To test 
whether eIF4E2 allows for HIF-2α and RBM4 
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to bind to the cap, we performed cap-binding 
assays with beads that have a 5’ cap attached, 
mimicking an mRNA 5’ cap. When eIF4E2, 
but not eIF4E, was depleted from cells, HIF-
2α and RBM4 could no longer bind to the 5’ 
cap-linked beads indicating that eIF4E2 was 
the cap-binding component that allowed for 
hypoxic cap-dependent translation to occur. 
Furthermore, reducing cellular eIF4E2 caused a 
global reduction in newly synthesized proteins 
specifically during hypoxia, but not in normal 
oxygen conditions.  A switch between the as-
sociation of eIF4E and eIF4E2 with polysomes 
could be observed between normal oxygen 
conditions and hypoxia. eIF4E was mostly as-
sociated with polysomes under normal oxygen 
conditions, but shifted away from these during 
hypoxia. Conversely, eIF4E2 was enriched in 
polysomes only during hypoxia. This switch of 
eIF4E2 into polysomes was dependent on the 
presence of HIF-2α (Fig. 1B).
WHAT DOES IT MEAN?
We have identified a translation mechanism 
that functions independently of eIF4E. This 
alternative cap-dependent translation mecha-
nism utilizes a related protein to eIF4E (eIF4E2) 
that escapes global translation repression by 
hypoxia. This finding furthers our under-
standing of how cells adapt to low oxygen 
availability. As mentioned in the introduction, 
many physiological processes depend on these 
hypoxic responses. Evidence in the literature 
suggests the importance of this eIF4E2-di-
rected translation pathway in many of these 
processes. Mice that lack HIF-2α or eIF4E2 die 
during foetal development. Muscles engaged 
in intense activity require proteins involved in 
aerobic metabolism, which are mRNA targets 
of HIF-2α and RBM4. Populations that live in 
the mountains of Tibet, altitudes that would 
be lethal to most people, have acquired a point 
mutation in the HIF-2α gene that allows them 
to thrive at these altitudes. Interestingly, this is 
the most rapid evidence of natural selection in 
a human population. It took under 3,000 years 
since the Tibetan highlanders separated from 
the lowlanders and migrated up the mountain. 
The previous record was the appearance of 
the lactase gene (the ability to digest milk) in 
Northern Europeans. Diseases such as stroke 
may depend on eIF4E2-dependent translation 
pathway. There is evidence that overexpressing 
HIF-2α in stroke patients is neuro-protective. 
Tumors with elevated HIF-2α are more aggres-
sive, and eIF4E2 is one of six genes that are 
strong predictors of metastasis in a variety of 
cancers.
 eIF4E2 is conserved across most eukary-
otes. In the fruit fly Drosophila melanogaster, 
eIF4E2 is named 4EHP and participates in 
the translation regulation of specific mRNAs 
involved in embryonic development. In the 
roundworm Caenorhabditis elegans, an im-
portant part of its life cycle is the burrowing for 
food deep in the earth where there is a lack of 
oxygen. In this animal, eIF4E2 is named ife-4, 
and it has been shown to be involved in the 
selective translation of key mRNAs required 
for survival. In the fission yeast, Schizosacaro-
myces pombe, eIF4E2 is required for the ad-
aptation to heat shock, salt stress and glucose 
starvation. eIF4E2 is a poor competitor for the 
5’ cap of mRNA in normal conditions, but this 
changes during hypoxia when eIF4E is inhib-
ited allowing eIF4E2 the opportunity to inter-
act with mRNA. We have identified a protein 
synthesis pathway that could be important 
across the animal kingdom for the adaptation 
to stress, namely low oxygen availability, which 
is a stress that plagues most multicellular ani-
mals.
FUTURE DIRECTIONS
Many questions still remain unanswered. 
How does eIF4E2 activate translation without 
interacting with a scaffolding protein like the 
eIF4G that eIF4E interacts with? To address this 
question, it would be necessary to identify all 
the proteins that interact with eIF4E2 during 
hypoxia. Another point that needs to be ad-
dressed is how diseases such as cancer utilize 
hypoxic translation to their advantage. Do can-
cers require eIF4E2-directed hypoxic translation 
to progress into large deadly hypoxic tumors 
that resist standard treatments? Studies should 
be performed across a variety of tumor-forming 
cancers to test whether these rely on eIF4E2 en 
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route to tumor progression. Cancer cells deplet-
ed in eIF4E2 could be monitored for their 
ability to form tumors in a test tube and then in 
a mouse model, for example. It is exciting times 
in science when a classical molecular mecha-
nism of cell biology such as protein synthesis 
still has many new discoveries on the horizon.
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 Q&A WITH THE AUTHOR 
What is your day-to-day work life like as a 
research scientist in Molecular & Cellular Biol-
ogy?
As an Assistant Professor in the Department of 
Molecular and Cellular Biology at the Universi-
ty of Guelph, my day-to-day work life involves 
managing a group of lab technicians, graduate 
students and undergraduate research project 
students. We all have the same goals to better 
understand how cells adapt to low oxygen 
availability and how this relates to human 
health. Many of the ongoing projects in my lab 
are attempting to answer some of the questions 
brought up in the Future Directions section of 
this article. Every lab member has his or her 
own project and we hold weekly lab meetings 
to discuss our findings or get advice from the 
rest of the group.
What is the most fulfilling aspect of working in 
your research field?
The most fulfilling aspects of working in the 
fields of molecular biology of human health are 
the partnerships with industry that can be built 
to achieve drug development or policy change. 
Seeing your research put into action and posi-
tively affecting human life is what we strive for 
in our field.
What are the biggest challenges faced by your 
field of research today?
The biggest challenge facing my field of re-
search is funding. There have been budget cuts 
across most government and private funding 
agencies that have had significant impacts 
on research in the human health field. More 
than ever, we have competent up-and-coming 
young scientists and sophisticated technology 
to perform research, but available money has 
been the limiting factor in recent history.   
What advice would you give to high school 
and undergraduate students interested in Mo-
lecular and Cellular Biology?
I would recommend choosing a major that 
will allow you to develop your lab skills in 
molecular and cellular biology techniques. I 
would suggest speaking with professors about 
their research and asking about volunteering 
or research project positions in their labs. It 
is important to get into a lab early on to see 
what type of research you enjoy or what field 
inspires you. Being in a lab early will also give 
you access to mentors such as graduate stu-
dents and postdoctoral fellows to guide you in 
your early career.
